glp-1 kidney outcomes news Renal effects of receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Kidney Outcomes With Glucagon-Like Peptide-1
Description
Your doctor will determine the correct dose and how often you should take it
N Engl J Med 2016;375: 311-22
They recommend ongoing surveillance as with any medication, but they havent found evidence of increased risk
Why GLP-1 Medications Are Reshaping Weight Loss These medications were originally developed for patients with type 2 diabetes, but their effects on appetite regulation, insulin sensitivity and inflammation quickly pushed them into the spotlight for weight loss
They do come with some risks and side effects, which are mostly mild and transient, but there are also significant benefits in risk reductions associated with lower blood sugars and weight loss
Our Tirzepatide Program is for those seeking the most advanced option on the market
